| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 40.024 | 60.002 | 60.695 | 57.187 | 59.731 | 57.733 | 59.457 | 54.041 |
| Total Income - EUR | - | - | 40.207 | 60.054 | 61.512 | 57.497 | 60.800 | 59.803 | 59.861 | 54.526 |
| Total Expenses - EUR | - | - | 32.965 | 50.149 | 52.256 | 48.706 | 56.741 | 56.939 | 68.032 | 59.021 |
| Gross Profit/Loss - EUR | - | - | 7.242 | 9.905 | 9.256 | 8.791 | 4.059 | 2.863 | -8.171 | -4.495 |
| Net Profit/Loss - EUR | - | - | 6.839 | 9.305 | 8.641 | 8.424 | 3.491 | 2.265 | -8.770 | -5.040 |
| Employees | - | - | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vapomed Business S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 532 | 153 | 0 | 4.649 | 4.753 | 4.120 |
| Current Assets | - | - | 10.173 | 20.474 | 37.444 | 43.615 | 52.445 | 48.478 | 42.844 | 45.016 |
| Inventories | - | - | 892 | 2.556 | 7.583 | 9.369 | 15.272 | 22.858 | 14.100 | 8.523 |
| Receivables | - | - | 0 | 0 | 0 | 240 | 3.654 | 734 | 157 | 2.791 |
| Cash | - | - | 9.281 | 17.918 | 29.861 | 34.006 | 33.519 | 24.886 | 28.587 | 33.702 |
| Shareholders Funds | - | - | 6.883 | 16.061 | 24.391 | 32.353 | 35.127 | 37.501 | 28.618 | 23.418 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.289 | 4.413 | 13.585 | 11.416 | 17.318 | 15.626 | 18.980 | 25.718 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Vapomed Business S.r.l.